News summarySeeking AlphaNov 4, 2026, 06:25 PM
Royalty Pharma raises 2026 portfolio receipts guidance to $3.5B-$3.55B while outlining $1.7B-plus future peak royalties
Royalty Pharma raises 2026 portfolio receipts guidance to $3.5B-$3.55B while outlining $1.7B-plus future peak royalties(摘要待生成)